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Abstract
The L-δ-(α-aminoadipoyl)-L-cysteinyl-D-valine synthetase (ACVS) is a nonribosomal pep-
tide synthetase (NRPS) that fulfills a crucial role in the synthesis of β-lactams. Although
some of the enzymological aspects of this enzyme have been elucidated, its large size, at
over 400 kDa, has hampered heterologous expression and stable purification attempts.
Here we have successfully overexpressed the Nocardia lactamdurans ACVS in E. coli
HM0079. The protein was purified to homogeneity and characterized for tripeptide formation
with a focus on the substrate specificity of the three modules. The first L-α-aminoadipic acid-
activating module is highly specific, whereas the modules for L-cysteine and L-valine are
more promiscuous. Engineering of the first module of ACVS confirmed the strict specificity
observed towards its substrate, which can be understood in terms of the non-canonical pep-
tide bond position.
Introduction
Nonribosomal peptides (NRP) represent a very versatile group of low to medium molecular
weight compounds that exhibit various biological activities. These peptides are exclusively pro-
duced by nonribosomal peptide synthetases (NRPS) and do not only contain proteinogenic
amino acids, but may also contain a wide variety of non-proteinogenic amino acids and
hydroxy acids [1]. NRP often undergo a series of modifications in cis, whether through the
action of the NRPS or by further tailoring enzymes.
NRP synthesis universally starts in every module with the adenylation (A) domain, serving
as a highly selective gate keeper, which recruits and adenylates a specific substrate, thereby
forming an acyl-adenylate conjugate. Subsequently, the substrate-conjugate is transferred to
the thiolation (T) domain by means of the phosphopantetheine (ppant) arm, with the AMP
being released. The ppant arm is a CoA (Coenzyme A)-derived cofactor, covalently attached to
a highly conserved residue of serine of the T domain by a ppant-transferase. The activated sub-
strates are then transported to the donor and acceptor sites of the up- or downstream
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condensation (C) domains, where peptide formation occurs with the upstream substrate being
released from the ppant moiety, and the newly synthesized intermediate ready to be trans-
ported to the next condensation domain [2–6]. In some cases, the growing peptide can be fur-
ther modified by accessory domains, such as N-methylation, substrate epimerization, and
heterocyclization domains [7][8]. When the synthesis is completed, the peptide is often
released via the activity of a thioesterase (Te) domain, either by macrocyclization or hydrolysis,
resulting in a cyclic or a linear NRP, respectively [8][9].
Despite extensive efforts, including the solution of sub-domain, domain, di-domain and
entire modular structures [5,10–14], the high conformational dynamics and flexibility that
characterize NRPS enzymes [15] have rendered structural analysis a considerable challenge.
Only recently the first structures of a dimodular NRPS were obtained [16], providing crucial
information on the dynamics of inter-domain and inter-module interactions and, ultimately,
NRP synthesis.
Due to the relative simplicity and overall significance, the β-lactam production pathway
[17–22] has been a paradigm for related research fields. Three distinct enzymatic steps are
involved in the production of β-lactams, with the trimodular NRPS L-δ-(α-aminoadipoyl)-
L-cysteinyl-D-valine synthetase (ACVS) providing the tripeptide (L,L,D)-ACV as the pre-
cursor for β-lactam antibiotics, such as penicillins or cephalosporins (Fig 1). The three
amino acids L-α-aminoadipic acid (L-α-Aaa), L-cysteine and L-valine are inserted in the
final product in a co-linear fashion, thus the position of the incorporated substrate corre-
sponds to the position of the respective module within the primary NRPS sequence [23].
Peptide formation itself is strictly determined by the selectivity of the domains of the ACVS.
Furthermore, L-α-aminoadipic acid is adenylated on the δ-carboxyl group, resulting in a
non-canonical peptide bond formation between L-α-Aaa and L-Cys. Lastly, L-valine is epi-
merized via an intrinsic epimerization (E) domain, located in the third module. The final
product is released as a linear tripeptide, (L,L,D)-ACV, by a Te domain, and it is subse-
quently converted to isopenicillin N by the enzyme isopenicillin N synthase (IPNS), which
catalyzes the formation of the β-lactam ring.
ACVS served as a model NRPS, aiding to establish the nonribosomal route of peptide pro-
duction. The protein has been studied in filamentous fungi such as Penicillium, Aspergillus,
Cephalosporium as well as bacterial Nocardia and Streptomyces species [24–30]. The partial
biochemical reactions of the NRPS domains have been examined mostly by using crude cell
extracts or partially purified enzyme [30]. The large size of the protein, 404–425 kDa [30],
makes expression and purification challenging for biochemical characterization. Here, we
focus on the pcbAB gene of Nocardia lactamdurans that encodes a 404 kDa ACVS, first enzyme
of the cephamycin biosynthetic pathway in this organism [29]. This protein was previously
overexpressed in Streptomyces lividans, purified to near homogeneity and characterized for
ACV synthetase activity. The enzyme activity was measured using 14C-valine in an ATP/PPi
exchange assay [31]. Here, we heterologously overexpressed Nl ACVS in E. coli HM0079 [32],
a platform strain that carries the 40-phosphopantetheine transferase gene sfp, crucial for the
production of active holoenzymes. The protein was purified to homogeneity and characterized
for tripeptide production and substrate promiscuity via HPLC-MS. This allowed for the deter-
mination of fundamental biochemical parameters and substrate specificity of the individual
modules. Furthermore, we engineered the adenylation domain of the first module of ACVS,
adapting a subdomain swap strategy [33][34] with the goal of generating hybrid NRPSs able to
activate alternative substrates and incorporate these at the first position of the tripeptide for
novel β-lactam production.
PLOS ONE Characterization of the N. lactamdurans ACVS
PLOS ONE | https://doi.org/10.1371/journal.pone.0231290 April 10, 2020 2 / 16
the author are articulated in the ‘author
contributions’ section.
Competing interests: The authors confirm that
author R. A. L. Bovenberg receiving salary from
DSM Biotechnology does not alter adherence to
PLOS ONE policies on sharing data and materials.
Furthermore, there are no relevant patents,
products in development or marketed products to
declare.
Results
Purification and biochemical characterization of the N. lactamdurans
ACVS
The Nocardia lactamdurans ACVS was overexpressed in E. coli HM0079 as a C-terminal
6xHis-tagged protein, and purified by Ni2+ affinity purification. The overall yield was
13.9 ± 3.4 mg pure ACVS per liter of culture (Fig 2). The purified enzyme (fraction E3) was
subjected to in vitro product formation assays using conditions outlined in the methods sec-
tion. In these assays, varying concentrations of the three substrate amino acids were used (Fig
3). Reactions were evaluated over a 4 h time course, and analyzed by HPLC/MS. Resulting
ACV levels were quantified and normalized, showing a near linear product formation over the
entire time course (Fig 3A–3C). Maximal ACV product levels under the given conditions
reached nearly 50 μM, exceeding the enzyme concentration (0.17 μM) by almost three orders
of magnitude, indicating multiple turnovers. The calculated Vmax value for the ACVS activity
was 0.78 ± 0.14 μM (ACV)�min-1�μM enzyme-1. Apparent KM values were determined from
the Michaelis-Menten kinetics with a>98% curve fit. Values of 640 ± 16, 40 ± 1 and
150 ± 4 μM were obtained for L-α-aminoadipic acid, L-cysteine and L-valine, respectively (Fig
3D).
Fig 1. ACVS domain organization and product formation. The ACVS consists of a total of 10 domains arranged in three modules with distinct specificities for
the incorporation of L-α-aminoadipic acid (L-α-Aaa), L-cysteine and L-valine into the tripeptide δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine ((L,L,D)-ACV).
The domain arrangement is conserved [30] and follows the order: AT-CAT-CATETe. The resulting (L,L,D)-ACV is converted into isopenicillin-N (IPN) by the
isopenicillin-N synthetase (IPNS). Following different biosynthetic routes, IPN can further be converted into penicillins, cephalosporins, cephamycins and
related compounds. In the circle, a schematic representation of the strategy [33] adopted to engineer the specificity of the first module of Nl ACVS is shown.
https://doi.org/10.1371/journal.pone.0231290.g001
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Substrate specificity of the Nl ACVS
Next, we determined the enzyme substrate specificity. Therefore, three sets of reactions were
arranged, varying the substrate for each of the three ACVS modules, also using structural ana-
logues. The concentration of the variable amino acid was set at 5 mM. Product levels were
determined as end points after 4h and analyzed for formation of the predicted tripeptides and
related structures using HPLC/MS (Fig 4). In addition to the three native substrates, 17 ana-
logues were tested in a total of 25 reaction setups (Table 1). Next to the ACV tripeptide, we
detected 11 of the expected tripeptides (M1: 3; M2: 5; M3: 3) as well as the AC-Cys tripeptide
in a reaction using L-α-Aaa and L-Cys only (S1 Appendix). Based on extracted ion count, pro-
duction levels vary strongly for the various tripeptides, from 0.003% up to 13.8% relative to
ACV production levels, assuming the same degree of ionization for the alternative tripeptides,
for which no chemical standard was available (Table 1).
Three sets of reactions were analyzed varying the amino acid on one position within the
tripeptide. Alternative substrates were added to a concentration of 5 mM, replacing either
L-α-Aaa (M1), L-Cys (M2) or L-Val (M3). Reactions (numbered 1–26) were evaluated
using LC/MS and peaks of interest were assessed according to accurate monoisotopic mass
(Mi). The resulting levels were set relative to the production of ACV (= 100), assuming simi-
lar ionization. Values derived from two biological and technical replicates ± standard devia-
tion (except for DL-aminopimelic acid and 2-oxoadipic acid reactions, with only two
technical replicates).
Fig 2. Ni2+ affinity chromatography purification of the Nocardia lactamdurans ACVS. Nl ACVS was isolated from
E. coli HM0079 cells and harvested after overnight expression at 18 ºC. A cell-free lysate was obtained through
sonication and subsequently separated into a clear supernatant (CFL) and the pellet was resuspended in 8 M Urea
(CFL (i)). The clear lysate was further purified using gravity flow in combination with a His-tag affinity
chromatography, using two washing steps (W1, W2) and elution with 50, 150 and 250 mM imidazole, respectively (E1,
E2, E3). Marker lane shows reference proteins corresponding to 170 and 130 kDa.
https://doi.org/10.1371/journal.pone.0231290.g002
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Engineering of the first adenylation domain of Nl ACVS
Next, we constructed a set of hybrid NRPS enzymes, by replacing the L-α-aminoadipic acid-
specific subdomain of the first adenylation domain of Nl ACVS with alternative amino acid
sequences from donor NRPSs (S1 Fig). Herein, the word subdomain is used to define specific
regions of the adenylation domains which meet distinct criteria, determined by Kries and
coworkers [33]. Donor NRPSs were selected according to their substrate specificities: the alter-
native sequences were chosen to explore the possibility to engineer hybrids that would activate
and incorporate amino acids with different types of side chains (L-glutamic acid, L-aspartic
acid, L-threonine, L-leucine, L-tyrosine and L-valine). One of the subdomains (L-valine-spe-
cific) was selected from the third module of Nl ACVS itself. We further included the L-α-ami-
noadipic acid-specific subdomain from the first module of Penicillium chrysogenum ACVS,
with a subdomain sequence identity of 48.5%, as a control. The complete set of subdomains
used in the engineering strategy is listed in Table 2. The amino acid sequences encoding the
substrate-specific subdomains were identified through multi-sequence alignment analysis, as
outlined in the methods section and in Fig 5. Hybrid NRPS constructs were built using a sys-
tem (S2 Fig) based on the Golden Gate assembly, a synthetic biology method that allows easy
Fig 3. Enzymatic characterization of ACVS. Three reaction series were conducted using various concentrations of L-α-Aaa (A), L-Cys (B) and L-Val (C) and
analyzed by LC/MS to quantify the amounts of the ACV tripeptide produced for Michaelis-Menten kinetics (D).
https://doi.org/10.1371/journal.pone.0231290.g003
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and seamless assembling of smaller DNA fragments into larger genes [34]. All the intermediate
vectors utilized in the assembly strategy were successfully cloned in E. coli DH5α and
sequenced individually. The Golden Gate assembly reactions for the hybrid NRPSs, which
were named ECVS, DCVS, TCVS, LCVS, YCVS, VCVS and PcANlCVS (according to the pre-
dicted specificity of the hybrid module), were performed in vitro and transformed directly into
E. coli DH5α cells for storage and sequencing.
Hybrid NRPS genes were overexpressed in E. coli HM0079 as C-terminal 6xHis-tagged pro-
teins, and purified by Ni2+ affinity purification as described for the wild-type Nl ACVS. The
overall yield was slightly lower compared to the Nl ACVS, ranging between 4 and 9 milligrams
of pure protein per liter of culture (Fig 6A). Next, the purified hybrids were subjected to in
vitro product formation assays including the amino acid substrates required for product for-
mation. The full HPLC/MS chromatograms were analyzed and filtered for the m/z values spe-
cific to the predicted tripeptides (S3 Fig). Only in one case we detected the production of the
expected compound. The hybrid PcANlCVS produced the ACV tripeptide, though at consid-
erably lower levels compared to the wild-type Nl ACVS (Fig 6, panels B and C).
Discussion
Here we report on the characterization of the Nocardia lactamdurans ACV synthetase, heterol-
ogously overexpressed in E. coli HM0079 [32] and purified to homogeneity. The aforemen-
tioned E coli strain contains a genomic copy of sfp, a phosphopantheteinyl transferase,
essential to activate the apo-ACVS to its active holo-form. An efficient purification process
was developed to obtain highly pure enzyme. Initial enzymatic characterization was performed
Fig 4. Substrate promiscuity of the N. lactamdurans ACVS: Structures of expected tripeptides. The predicted
structures of the novel tripeptides and their corresponding reactions are numbered 1–26 (see Table 1). Italic numbers
indicate production of the respective tripeptide. � = ACC tripeptide derived from L-α-Aaa and L-Cys only (26).
https://doi.org/10.1371/journal.pone.0231290.g004
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by following the production of the tripeptide ACV. With respect to the three ACVS modules,
distinct differences in substrate affinities were noted with the initiating L-α-aminoadipic acid
module showing the lowest affinity for its substrate. Previous studies on the formation of prod-
uct intermediates and partial reactions of NRPS enzymes suggest that the initial amino acid
thiolation reaction is a rate limiting step in the assembly of nonribosomal peptides, necessary
for the subsequent domains to adopt their distinct conformations for peptide bond formation
Table 1. ACVS substrate promiscuity.
Analogue Tripeptide # Mi rel prod (±err)
ACVS - (L,L,D)-ACV 1 363,146 100 ± 10.3
M1 L-Aspartic acid Asp-CV 2 335,115 0
L-Glutamic acid Glu-CV 3 349,131 0.02 ± 0.009
DL-aminopimelic acid API-CV 4 377,162 0.01
DL-aminosuberic acid ASU-CV 5 391,178 0
2-oxoadipic acid OAA-CV 6 362,115 0.003
Phenoxyacetic acid POA-CV 7 354,125 0
Adipic acid AA-CV 8 348,136 0
M2 L-Alanine A-Ala-V 9 331,174 0.98 ± 0.02
L-Glycine A-Gly-V 10 317,159 0
DL-Homocysteine A-Hcys-V 11 377,162 0
L-Serine A-Ser-V 12 347,169 0
L-Threonine A-Thr-V 13 361,185 0.02 ± 0.003
L-Penicillamine A-Pen-V 14 391,178 0.05 ± 0.005
L-Methionine A-Met-V 15 391,178 0.07 ± 0.01
L-Leucine A-Leu-V 16 373,221 1.58 ± 0.21
L-Isoleucine A-Ile-V 17 373,221 0
M3 L-Norvaline AC-NorVal 18 363,146 13.8 ± 0.59
L-Leucine AC-Leu 19 377,162 0.54 ± 0.01
L-Isoleucine AC-Ile 20 377,162 1.21 ± 0.04
L-Threonine AC-Thr 21 365,126 0
L-Methionine AC-Met 22 395,118 0
L-Penicillamine AC-Pen 23 395,118 0
L-Glycine AC-Gly 24 321,099 0
L-Alanine AC-Ala 25 335,115 0
L-Cysteine AC-Cys� 26 367,087 13.6 ± 1.93
https://doi.org/10.1371/journal.pone.0231290.t001
Table 2. Set of subdomains selected for the engineering strategy.
Subdomain ID Parent NRPS UniProtKB
Accession No.
Organism of origin subdomain boundaries (aa)
Nl ACVS subAad ACV synthetase P27743 Nocardia lactamdurans 442–577
Nl ACVS subVal ACV synthetase P27743 Nocardia lactamdurans 2583–2715
TycC subLeu Tyrocidine synthase 3 O30409 Brevibacillus parabrevis 5839–5975
TycC subTyr Tyrocidine synthase 3 O30409 Brevibacillus parabrevis 2718–2854
PsoA subGlu PsoA A8MN36 Pseudomonas putida 1702–1742
DptA subAsp DptA Q50E74 Streptomyces filamentosus 3271–3399
EndA subThr EndA Q06YZ3 Streptomyces fungicidicus 1686–1826
Pc ACVS subAad ACV synthetase P26046 Penicillium chrysogenum 515–649
https://doi.org/10.1371/journal.pone.0231290.t002
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and product release [6][36]. Overall, substrate affinities levels appear to be in line with other
ACVS homologues, in particular prokaryotic enzymes [37].
We furthermore determined the substrate specificity of the ACVS modules within the con-
text of the complete enzyme, by assessing the production of predicted tripeptides (Table 1 and
Fig 4). Some ACVS homologues [31,38–40] exhibit a certain degree of substrate tolerance,
despite considerably tight control mechanisms that assure correct product formation. With
the N. lactamdurans ACVS, replacement of L-α-aminoadipic acid by substrate analogues
yielded only trace amounts of Glu-CV, previously reported [38,40], and API-CV and
Fig 5. Subdomains multi-alignment and boundaries determination. (A) Multi-alignment of the subdomains used in
the engineering strategy proposed by Kries and coworkers [33]. The two residues highlighted in yellow in the
consensus sequence represent the first highly conserved motif with a phenylalanine and the aspartic acid which forms
a hydrogen bond with the α-amino group of the amino acid substrate [35]. The motifs highlighted with the red boxes
represent the conserved motifs identified as boundaries of the subdomains in the consensus sequence. (B) Multi-
alignment of the subdomains selected for this work; in absence of structural information the conserved motifs at both
ends were used to determine the subdomain boundaries.
https://doi.org/10.1371/journal.pone.0231290.g005
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OAA-CV tripeptides, while none of the other substrates tested were incorporated. The struc-
tures of the three analogues activated strongly resemble that of L-α-Aaa, thus indicating a strict
specificity for module 1. With the second module (L-cysteine), two alternative tripeptides
A-Ala-V and A-Leu-V were generated in substantial amounts while trace amounts of three
other A-X-V tripeptides were found (Table 1 and Fig 4). This suggests that this module is
more promiscuous. Finally, for the third module (L-valine), two novel products AC-Leu and
AC-Ile were observed at a level of 0.5–1%, while AC-NorVal was found at levels over 13% rela-
tive to ACV. Module 3 shows some tolerance towards side chain length and the distribution of
methyl-groups. However, substrates with hydroxyl or thiol groups are not incorporated. In
addition, in the absence of L-valine, we observed the production of a putative AC-Cys tripep-
tide up to a level of 13%. While these results indicate that the individual modules can accept
only certain substrates, it cannot be entirely excluded that some tripeptides are not synthesized
because of weaker activity towards the alternative substrate in downstream activities, such as
the condensation reaction.
Modules 2 and 3 of the Nl ACVS exhibit some degree of tolerance towards substrates that
are structurally similar to the native ones, yielding significant levels of tripeptides. In marked
contrast, module 1 accepted only three alternative substrates, L-Glu, DL-aminopimelic acid
and 2-oxoadipic acid, resulting in the production of trace amounts of tripeptides. With L-Asp
and DL-aminosuberic acid, no tripeptide could be detected. Considering the strong similarity
of these structures with L-α-Aaa, it seems very clear that the length of the side chain is of cru-
cial importance. The presence of the α-NH2 group appears to be crucial as well, as only trace
amounts of tripeptide were detected in the reaction with 2-oxoadipic acid, while adipic acid
was not incorporated at all (Table 1).
Importantly, in the structure of ACV, the peptide bond between the first two amino acids
occurs between the δ-carboxyl group of L-α-Aaa and the amino group of L-Cys (Fig 1). Thus,
Fig 6. Overexpression and activity assays of the hybrid NRPSs. (A) SDS-PAGE analysis of the purified fractions of the hybrids: only fraction E2 (150 mM
imidazole) is shown. Marker lane shows reference protein corresponding to 180 kDa. (B) In vitro tripeptide production assays with hybrid enzymes. (C) The
production of the tripeptide ACV was confirmed by accurate monoisotopic mass and equal retention time compared to the wild-type enzyme product and an
ACV synthetic standard.
https://doi.org/10.1371/journal.pone.0231290.g006
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L-α-Aaa must be adenylated on the side chain, in contrast with the canonical mechanism of
activation of the C-α carboxyl group of amino acid described for other bacterial NRPSs [35]
[41]. Nonetheless, module 1 remains the most interesting target for potential engineering
approaches, as the cysteine and valine are essential for β-lactam ring formation, while the ami-
noadipate is exchanged with other moieties in the (semi-) biosynthetic pathway of penicillins.
Theoretically, by achieving activation and incorporation of alternative substrates at the first
position, novel compounds with antibiotic activity could be generated.
Therefore, we proceeded with engineering the specificity of the adenylation domain of module
1. Several strategies have been used in the past to engineer NRPS enzymes with the goal of pro-
ducing modified compounds, amongst which subdomain-, domain- and full module- exchanges,
active site modification and directed evolution [33,42–47]. Herein, we designed a strategy based
on the Golden Gate assembly method [34] and adapted from the work of Kries and coworkers on
the Phe-specific GrsA initiation module of gramicidin S synthetase [33]. Using this strategy, we
successfully generated 7 hybrid NRPS genes that could be expressed in E. coli HM0079 and puri-
fied. The peptide production assays and LC-MS analyses, however, revealed that only one of the
hybrids was able to produce the expected tripeptide in an in vitro reaction, though at much lower
levels. More specifically, the hybrid PcANlCVS, with the same specificity as the native Nl ACVS,
but with the subdomain region “implanted” from its Penicillium chrysogenum homologue.
While the difference in amino acid sequence between the fungal and bacterial ACVS was
not a limiting factor, the narrow substrate range of the native enzyme seems to pose a greater
obstacle to the engineering of functional NRPS hybrids with alternative specificities. Therefore,
such engineering approaches could prove more successful when targeting naturally promiscu-
ous enzymes. Recently it was reported that condensation domains also show specificity
towards upstream activated substrate [48][49], and therefore exert an extra gate-keeping func-
tion. Thus, the chemistry of the ACVS reaction, the tight specificity shown by the first adenyla-
tion domain and its noncanonical interaction with the substrate, as well as the possibility of a
second gate-keeping checkpoint on the condensation domain of module 2, all present signifi-
cant challenges to the engineering of a functional hybrid ACVS capable of producing alterna-
tive tripeptides. Additionally, until the intra-NRPS reaction dynamics, conformational timing
and structural organization of a multi-modular NRPS enzymatic system have been elucidated,
global engineering efforts will remain challenging for this class of enzymes.
Materials and methods
Strains, plasmids and general culturing conditions
All cloning procedures were performed using E. coli DH5α. Cultures were grown using LB
medium at 37 oC and 200 rpm and antibiotic selection was conducted utilizing 25 μg/mL Zeo-
cin. The Nocardia lactamdurans pcbAB was cloned using an intermediate gateway vector and
was subsequently sub-cloned into the pBAD-plasmid (pBR322 ori; araC; pBAD, ZeoR) using
SbfI x NdeI sites and including the introduction of a 6xHis-tag on the C-terminal end. This
construct was kindly provided by DSM Sinochem Pharmaceuticals (now Centrient Pharma-
ceuticals). The synthetic DNA fragments encoding the donor subdomains were designed in sil-
ico and purchased from Invitrogen (GeneArt Strings). In silico PCR and cloning procedures,
as well as subsequent analyses, were performed using the SnapGene1 software (from GSL
Biotech; available at snapgene.com).
Identification of swapping partners and multi-alignment analysis
Donor NRPS were identified using the database NORINE [50]. For each of the substrate speci-
ficities that were selected for the engineering strategy (L-glutamic acid, L-aspartic acid, L-
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threonine, L-leucine and L-tyrosine), the database was searched using the function “monomer
search”. The resulting hits were further selected based on sequence identity to the first adenyla-
tion domain of Nl ACVS, the size of the subdomains (determined according to the criteria
described previously by Kries et al. [33]) and the identity between the putative donor subdo-
mains and the L-α-aminoadipic acid-specific subdomain (S1 Fig). All alignment analyses were
performed using the software MEGA7 [51] and Unipro UGENE [52]. The sequences of the
complete adenylation domains from the donor NRPS were all aligned to the sequences of the
subdomains designed and utilized by Kries and coworkers, to identify conserved motifs and
define subdomain boundaries (Fig 5). All the DNA fragments were designed in silico, with the
addition of the appropriate restriction sites, using the SnapGene1 software. The DNA frag-
ments were subsequently synthesized and purchased from Invitrogen (GeneArt Strings). The
L-Val specific subdomain from Nl ACVS M3 and the L-α-Aaa-specific subdomain from Pc
ACVS M1 were amplified via PCR from pBAD-Nl ACVS and P. chrysogenum DS47274
gDNA, respectively. KAPA HiFi HotStart ReadyMix (Roche) was used, according to the man-
ufacturer’s protocol.
Engineering of the first adenylation domain of Nl ACVS via a Golden Gate-
based subdomain swap strategy
The pBAD plasmid containing the gene encoding Nl ACVS was virtually divided in three frag-
ments, called A1, A2 and A3, designed in silico in such a way to exclude the Nl ACVS M1
native subdomain (S2 Fig). The three fragments were then individually amplified via PCR
using KAPA HiFi HotStart ReadyMix (Roche), according to the manufacturer’s protocol, and
sub-cloned into intermediate pMAL-c5x-BsrDI free vectors (mutated in house to remove the
recognition site BsrDI, type IIs restriction enzyme used in the Golden Gate assembly). The
DNA fragments encoding the selected subdomains were sub-cloned in the same intermediate
vector. The constructs were then checked via restriction analysis and sequencing (Macrogen
Inc.). Once all the parts were confirmed correct, Golden Gate assembly reactions were per-
formed to build the hybrid NRPSs. For this, the intermediate vectors pMAL-c5x-A1, pMAL-
c5x-A2, pMAL-c5x-A3 and pMAL-c5x-subx were mixed with a molar ratio of 1:1:0.5:1, with a
total amount of DNA ~ 500 ng. Subsequently, 1 μL of T4 DNA Ligase (5 U/μL), 1 μL of T4
DNA Ligase 10x buffer and 0.5 μL of BsrDI (5 U/μL) (Invitrogen, Thermo Fisher Scientific)
were added to complete the reaction mixture in a total volume of 10 μL. The Golden Gate
assembly reactions were carried out in a C1000 Thermal Cycler (Bio-Rad), with the standard
50x cycles-protocol [34]. The reaction mixtures were directly transformed into chemically-
competent E. coli DH5α cells. The plasmids were subsequently mini-prepped and checked as
described previously.
Expression and His-tag affinity purification of Nl ACVS and hybrid NRPSs
Cultures were grown to an OD600 of 0.6, transferred to 18˚C and 200 rpm for 1h and subse-
quently induced using 0.2% L-arabinose. Harvest followed 18h after induction by spinning at
4000 g for 15 minutes. After resuspension in lysis buffer (HEPES 50 mM pH 7.0, 300 mM
NaCl, 2 mM DTT, Complete EDTA free protease inhibitor; Roche No. 04693159001), cells
were disrupted using sonication (6s/15s on/off; 50x; 10μm amplitude; Soniprep 150 MSE) and
cell-free lysate obtained by centrifugation at 4˚C, 17000g, 15 minutes. Purified enzyme was
extracted by means of Ni2+ affinity purification using gravity flow. Wash steps were performed
using two column volumes of wash buffer (HEPES 50 mM pH 7.0, 300 mM NaCl, 20 mM
imidazole) followed by a three-step elution using one bed volume of each elution buffer
(HEPES 50 mM pH7.0, NaCl 300 mM, imidazole 50–150 or 250 mM). Samples were
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concentrated if necessary, using Amicon U-100 spin filters (Merck). Final concentration was
determined using A280 (NanoDrop 1000; Thermo Fisher Scientific).
In vitro product formation assay
Isolated enzymes (fraction E3) were subjected to in vitro assays, in order to determine product
formation properties. Assay conditions initially used include HEPES 50 mM pH 7.0, 300 mM
NaCl, 5 mM ATP pH 7.0, 100 μM CoA, 0.2 μM phosphopantetheinyl transferase (Sfp, NEB), 5
mM L-α-aminoadipic acid, 2 mM L-cysteine, 2 mM L-valine (5 mM L-Val for the hybrid
VCVS), 5 mM MgCl2, 2 mM DTT and 0.17 μM ACVS, or 0.5–1 μM for the hybrids. For veloc-
ity and affinity determination, amino acid concentration of 0.1, 0.25, 0.5, 1, 2 and 5 mM were
used. For the hybrids’ reactions and promiscuity determination the concentration of the vari-
able amino acid was set at 5mM. Reactions were run at 30˚C and sampling took place after 0,
10, 20, 30, 45, 60, 120 and 240 minutes for dynamic measurements and after 0 and 240 or 960
minutes for endpoint value determination. NaOH was added to each sample to a final concen-
tration of 0.1 M to quench the reactions. Samples were subsequently stored at -80˚C and
reduced before HPLC/MS analysis adding DTT to a concentration of 5 mM.
High performance liquid chromatographic and mass-spectrometric
analysis (HPLC/MS)
Samples (50 μL) obtained from an in vitro reaction were subjected to HPLC/MS analysis. Two
technical replicates were run per sample at 5 μL each. Analysis was performed using a LC/MS
Orbitrap (Thermo Scientific) in combination with a RP-C18 column (Shimadzu Shim pack
XR-ODS 2.2; 3.0x75mm). Scan range was set at 80–1600 M/Z in positive ion (4.2kV spray,
87.5V capillary and 120V of tube lens) mode, with capillary temperature set at 325˚C. A gradi-
ent program with MilliQ water (A), Acetonitrile (B) and 2% Formic acid (C) was run: 0 min, A
90%, B 5%, C 5%; 4 min, A 90%, B 5%, C 5%; 13 min, A 0%, B 95%, C 5%; 16 min, A 0%, B
95%, C 5%; 16 min, A 90%, B 5%, C 5%; 21 min, A 90%, B 5%, C 5% at a flow rate of 0.3 ml
min-1. The Bis-ACV standard was obtained from Bachem, reduced to (L,L,D)-ACV and used
for quantification in a standard curve at concentrations of 0.1, 0.5, 1, 5, 10, 50 and 100 μM.
Alternative tripeptides were identified according to accurate monoisotopic mass, if not men-
tioned otherwise.
Supporting information
S1 Fig. Selection criteria for donor subdomain templates. The donor subdomains were
selected according to three criteria. First, we individually aligned the full donor A domains to
the ACVS M1 A domain (L-Aaa) and determined the sequence identity (we selected those
with identity higher than 30% for further analysis, in green). We then determined the size of
the subdomain, using as boundaries the regions described in the methods section and Fig 5;
those with a similar size to the wild-type subdomain were aligned with the latter, to determine
the identity between the subdomains themselves. The ones with highest identity were selected
and designed in silico for the assembly strategy (highlighted in dark green). Targets with A
domains sequence identities below 30% were not further included in the analyses; �local mis-
alignments that prevented the determination of the subdomains boundaries.
(TIF)
S2 Fig. Golden gate-based subdomain swap strategy. (A) pBAD-Nl ACVS His-tag plasmid
map (exported from Snapgene). (B) Hybrid NRPSs assembly strategy: three fragments (named
A1, A2 and A3) were amplified via PCR from the plasmid in such a way to amplify the gene
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together with the vector and exclude the subdomain of module 1; the three fragments were
cloned into pMAL-c5x-BsrDI free intermediate vectors (BsrDI sites are presents at the ends of
the A1, A2 and A3 fragments for the Golden Gate assembly); the synthetic donor subdomains
(Asubx) are also cloned into the same intermediate vector. A1, A2, A3 and Asubx have comple-
mentary overhangs (indicated by numbers 1–4) after digestion with BsrDI, allowing the
Golden Gate assembly reaction.
(TIF)
S3 Fig. Predicted structures of hybrid tripeptides. The structures (wild-type product ACV
on top) were drawn using MarvinSketch (ChemAxon), and exact molecular weights were
determined using the ‘Elemental analysis’ tool of the same software.
(TIF)
S1 Appendix. LC chromatograms and mass spectra of characterized tripeptides. The full
chromatograms were filtered in accordance with the predicted m/z value of each tripeptide.
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